Compare OLB & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OLB | NVNO |
|---|---|---|
| Founded | 1993 | 1987 |
| Country | United States | United States |
| Employees | N/A | 37 |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2M | 7.2M |
| IPO Year | 2019 | N/A |
| Metric | OLB | NVNO |
|---|---|---|
| Price | $0.54 | $10.08 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 421.6K | 13.6K |
| Earning Date | 05-14-2026 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,838,988.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.52 | $140.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.31 | $0.30 |
| 52 Week High | $2.50 | $12.85 |
| Indicator | OLB | NVNO |
|---|---|---|
| Relative Strength Index (RSI) | 44.08 | 49.38 |
| Support Level | $0.31 | $9.76 |
| Resistance Level | $0.71 | $12.69 |
| Average True Range (ATR) | 0.06 | 1.02 |
| MACD | -0.01 | -0.24 |
| Stochastic Oscillator | 33.64 | 28.83 |
The OLB Group Inc is a diversified fintech e-commerce merchant services provider and Bitcoin crypto mining enterprise. It focuses on a suite of products in the merchant services marketplace and seeks to provide integrated business solutions to merchants throughout the United States. Along with its subsidiaries, the company offers a cloud-based business management platform that provides turnkey solutions for merchants to enable them to build and manage their retail businesses, whether online or at a brick-and-mortar location, payment processing solutions, payment gateway, virtual terminal with proprietary business management tools, and crowdfunding solutions. The company has two business segments; Fintech Services which generates key revenue, and the Bitcoin Mining business segment.
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.